Log In
BCIQ
Print this Print this
 

MPC-06-ID

  Manage Alerts
Collapse Summary General Information
Company Mesoblast Ltd.
DescriptionAllogeneic mesenchymal precursor cells (MPCs) injected into a damaged disc in an outpatient procedure
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat chronic low back pain due to degenerative disc disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$21.6M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/22/2016

$21.6M

0

0

Get a free BioCentury trial today